Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
As of today, Natera(NTRA) shares are valued at $221.55. The company's market cap stands at 31.73B, with a P/E ratio of -130.35.
On 2026-05-29, Natera(NTRA) stock moved within a range of $211.40 to $225.70. With shares now at $221.55, the stock is trading +4.8% above its intraday low and -1.8% below the session's peak.
Trading volume for Natera(NTRA) stock has reached 1.2M, versus its average volume of 1.57M.
Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $256.36 and a low of $131.81.
Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $256.36 and a low of $131.81.
NTRA News
The United States market has shown robust performance, climbing 1.8% over the last week and 28% in the past year, with earnings forecasted to grow by 17% annual...
Why Natera Is My Favorite Stock Idea for the Rest of 2026 By Joey Frenette Published May 29, 10:26AM EDT Quick Read Stocks: Natera (NTRA) applies AI to cell-f...
Natera (NTRA) announced a new collaboration with Diakonos Oncology Corp., a clinical-stage biotechnology company developing immunotherapies to treat challenging...
Analyst ratings
90%
of 20 ratingsMore NTRA News
Natera (NTRA) announced enrollment of the first patients in SIgnatera-Guided iNterventionAL-ER 101, a prospective, single-arm, multi-center study evaluating Sig...
Natera, Inc. recently enhanced its Panorama non-invasive prenatal test with SNP-informed deep sequencing, showing strong performance even in low fetal fraction...
Natera (NasdaqGS:NTRA) announced a major upgrade to its Panorama non-invasive prenatal test that targets long-standing issues with low fetal fraction samples....
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.